Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

The National Parkinson Foundation Welcomes New Board Member

MIAMI, FL — The National Parkinson Foundation (NPF) announced the election of Ricardo Caporal to its Board of Directors. 

"We are delighted to welcome Ricardo to NPF’s Board. We are excited about using his entrepreneurial leadership and diverse skill set to make a difference in the lives of the more than one million Americans living with Parkinson’s," stated John W. Kozyak, Esq., NPF Chairman of the Board. “Ricardo has been successful with non-profits, real estate and a wide array of businesses, including music, fashion and technology. You can literally feel Ricardo’s energy and drive and I cannot wait for him to start serving.”

Ricardo Caporal is the Founder & President of Mattoni Group. The Brazil-born property developer has over 10+ years of real estate experience with a history of zest for entrepreneurship in an array of industries including music, fashion, design and technology. Additionally, he has worked in private equity. Caporal’s Mattoni Group real estate investment company includes partnership interests in a diverse portfolio of assets across the Southern part of the United States comprised of rental apartment communities and commercial properties.

Caporal established Mattoni Group in December 2009 with an aim to locate and create unique real estate investment opportunities. With a play on the word Mattoni which means “bricks” in Italian, Caporal’s vision has been to create building blocks by effectively developing and managing the properties under his portfolio so that they revitalize their surrounding communities, attract quality tenants and/or buyers, and produce long-term value. Currently, Mattoni Group handles 1,000+ units in South Florida.

Ricardo is active in local and national organizations and philanthropic causes, including the Young Presidents Organization (YPO) of Miami, where he has served as a member of the board’s Executive Committee.  Caporal graduated Magna Cum Laude and with honors from Babson College with degrees in both entrepreneurship and finance. Caporal was born in Sao Paulo, Brazil and currently lives in Miami, Florida with his wife and two children.

View a complete list of the NPF Board of Directors.

About Parkinson's Disease (PD)
Affecting an estimated one million Americans and four to six million worldwide, PD is the second most common neurodegenerative disease after Alzheimer's and is the 14th leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression and anxiety A feeling of nervousness, worried thoughts and physical distress.). There is no cure for PD and 60,000 new cases are diagnosed each year in the United States alone.

Wednesday, February 18, 2015
The Parkinson’s Foundation 2018 Gala in New York City Tuesday, May 8, 2018
Monday, May 14, 2018

The Parkinson’s Foundation 2018 Gala was held at Cipriani 25 Broadway in New York City on Tuesday, May 8, 2018.

Parkinson’s Foundation Adds Alison Herman to its Board of Directors
Tuesday, May 8, 2018

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

Statement on Nuplazid Drug
Tuesday, April 10, 2018

On 4/9/18, CNN published an article on the FDA-approved drug, Nuplazid, used to treat hallucinations and psychosis in Parkinson’s disease. The article investigates FDA data showing the number of reported deaths with people taking Nuplazid. Nuplazid was approved by the FDA in 2016 and is manufactured by Acadia Pharmaceuticals.

Parkinson’s Foundation Adds John D. Thomopoulos to its Board of Directors
Monday, March 19, 2018

MIAMI & NEW YORK – March 19, 2018 – The Parkinson’s Foundation today announced the election of John D. Thomopoulos to its board of directors. Thomopoulos is a partner at Ernst & Young.

In Memory of Edythe Kay Marsa
Monday, March 12, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member, Edythe (Edy) Kay Marsa. From 1993 to 2014, she was a member of the Foundation’s board of directors and served on several committees. Edy is survived by her husband William Marsa, who founded the Herbert Kay Parkinson Chapter in honor of her first husband who passed away due to complications from Parkinson’s disease.

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care
Tuesday, March 6, 2018

MIAMI & NEW YORK—March 6, 2018—The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network.

Delegates From The Parkinson’s Community Converge On Capitol Hill To Advocate For Critical Research Funding
Monday, March 5, 2018

—2018 Parkinson’s Policy Forum Co-Sponsored by the Parkinson’s Foundation and the Michael J. Fox Foundation for Parkinson’s Research—

Parkinson’s Foundation Appoints Jena E. Abernathy to Board of Directors
Tuesday, February 27, 2018

MIAMI – February 27, 2018 –  The Parkinson’s Foundation today announced the election of Jena E. Abernathy to its board of directors.

Parkinson’s Foundation Moving Day Walks Fund Local Parkinson’s Programs in Seven Cities for Spring 2018
Friday, February 16, 2018

NEW YORK & MIAMI, FEBRUARY 16, 2018 — The Parkinson’s Foundation is proud to announce that Moving Day, A Walk for Parkinson’s, has funded more than $17 million in mission services to make life better for people living with Parkinson’s disease (PD).

Terranova’s Stephen Bittel Donates $450,000 to Parkinson’s Foundation to Support Expansion of Centers of Excellence Network
Thursday, February 1, 2018

MIAMI – February 1, 2018 – The Parkinson’s Foundation today announced that Stephen Bittel, chairman and founder of Terranova, has made a $450,000 donation to support the expansion of the foundation’s Centers o

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.